Cigna Corp. (CI) Rating Reiterated by Leerink Swann
Cigna Corp. (NYSE:CI)‘s stock had its “buy” rating reissued by investment analysts at Leerink Swann in a research report issued to clients and investors on Monday. They currently have a $155.00 target price on the stock. Leerink Swann’s price objective would indicate a potential upside of 17.69% from the company’s previous close.
Several other equities analysts have also recently commented on the stock. Barclays PLC raised their price target on shares of Cigna Corp. from $156.00 to $168.00 and gave the company an “equal weight” rating in a research report on Wednesday, June 1st. FBR & Co reissued a “hold” rating on shares of Cigna Corp. in a research report on Monday, June 20th. Stifel Nicolaus initiated coverage on shares of Cigna Corp. in a research report on Tuesday, June 28th. They issued a “buy” rating and a $169.00 price target for the company. Wolfe Research initiated coverage on shares of Cigna Corp. in a research report on Tuesday, June 28th. They issued an “outperform” rating and a $172.00 price target for the company. Finally, Zacks Investment Research raised shares of Cigna Corp. from a “hold” rating to a “buy” rating and set a $144.00 price target for the company in a research report on Tuesday, July 5th. One analyst has rated the stock with a sell rating, six have issued a hold rating and ten have given a buy rating to the company’s stock. Cigna Corp. presently has an average rating of “Buy” and an average price target of $157.65.
Shares of Cigna Corp. (NYSE:CI) opened at 131.70 on Monday. Cigna Corp. has a one year low of $121.87 and a one year high of $148.99. The stock’s 50 day moving average is $129.93 and its 200-day moving average is $132.06. The stock has a market capitalization of $33.79 billion, a price-to-earnings ratio of 17.08 and a beta of 0.54.
Cigna Corp. (NYSE:CI) last posted its quarterly earnings data on Friday, July 29th. The company reported $1.98 earnings per share for the quarter, missing the Zacks’ consensus estimate of $2.39 by $0.41. The company had revenue of $9.89 billion for the quarter, compared to analysts’ expectations of $9.98 billion. Cigna Corp. had a return on equity of 17.60% and a net margin of 5.16%. The business’s revenue for the quarter was up 4.9% on a year-over-year basis. During the same period in the previous year, the business posted $2.55 EPS. On average, equities research analysts predict that Cigna Corp. will post $7.99 EPS for the current fiscal year.
In other Cigna Corp. news, VP Mary T. Hoeltzel sold 500 shares of the firm’s stock in a transaction on Wednesday, August 17th. The shares were sold at an average price of $132.28, for a total transaction of $66,140.00. Following the transaction, the vice president now directly owns 4,017 shares of the company’s stock, valued at approximately $531,368.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.20% of the company’s stock.
Several hedge funds have recently modified their holdings of the stock. AMP Capital Investors Ltd increased its stake in shares of Cigna Corp. by 1.3% in the first quarter. AMP Capital Investors Ltd now owns 207,983 shares of the company’s stock valued at $28,589,000 after buying an additional 2,769 shares during the last quarter. Magnetar Financial LLC increased its stake in shares of Cigna Corp. by 130.0% in the first quarter. Magnetar Financial LLC now owns 958,393 shares of the company’s stock valued at $131,530,000 after buying an additional 541,775 shares during the last quarter. York Capital Management Global Advisors LLC purchased a new stake in shares of Cigna Corp. during the first quarter valued at $49,327,000. Boston Advisors LLC increased its stake in shares of Cigna Corp. by 2.3% in the second quarter. Boston Advisors LLC now owns 139,258 shares of the company’s stock valued at $17,824,000 after buying an additional 3,113 shares during the last quarter. Finally, Squarepoint Ops LLC increased its stake in shares of Cigna Corp. by 2,120.3% in the first quarter. Squarepoint Ops LLC now owns 67,232 shares of the company’s stock valued at $9,226,000 after buying an additional 64,204 shares during the last quarter. 85.25% of the stock is currently owned by institutional investors and hedge funds.
Cigna Corp. Company Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, Other Operations and Corporate.
Receive News & Stock Ratings for Cigna Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corp. and related stocks with our FREE daily email newsletter.